Reproductive function and sperm parameters in men with sickle cell disease: a systematic review
Asian Journal of Andrology · 2026
DOI: 10.4103/aja202510 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Asian Journal of Andrology, 2026. Verfasst von Clarisse Leblanc und 12 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Biology Department, CECOS, Tenon Hospital, AP-HP. Sorbonne University, Paris 75020, France. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Spermatozoa, Infertility, Male, Reproduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sickle cell disease (SCD) is one of the most common hereditary diseases in the world. It leads to hemolytic anemia and painful vaso-occlusive crises that can damage target organs at the cardiopulmonary, cerebrovascular, and renal levels. SCD has also significant consequences on reproductive functions and fertility. Moreover, the treatments designed to alleviate and reduce vaso-occlusive crises directly impact male reproductive functions. Nevertheless, literature assessing the impact of SCD and its treatments on male reproductive functions remains limited and lacks robust evidence. A systematic review of the literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendation was carried out on the reproductive functions of men with SCD and the reproductive options available to them. Most studies have found that men with SCD frequently exhibit impaired sperm parameters. In addition, hydroxyurea (HU), proposed to relieve and reduce vaso-occlusive crises, is also known to impact male reproductive functions, and the reversibility of these consequences on sperm parameters remains hypothetical. Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment. However, conditioning treatments are highly gonadotoxic and can permanently alter spermatogenesis. Young men with SCD should therefore be informed about fertility at an early stage, and fertility preservation should be discussed in pubescent men, especially if treatment with HU or HSCT is to be initiated. In prepubertal boys about to undergo HSCT, immature testicular tissue freezing should be discussed, even though this technique is still experimental.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Biology Department, CECOS, Tenon Hospital, AP-HP. Sorbonne University, Paris 75020, France.
- Sorbonne University School of Medicine, Saint-Antoine Research Center, INSERM UMR 938, Paris 75012, France.
- Department of Internal Medicine, Reference Centre for Major Sickle Cell Syndromes, Tenon Hospital, AP-HP. Sorbonne University, Paris 75020, France.
- Department of Obstetrics and Gynaecology and Reproductive Medicine, Tenon Hospital, AP-HP. Sorbonne University, Paris 75020, France.
Zitieren
APA
Leblanc, C., Sermondade, N., Ogouma-Aworet, L., Ly, A., Rivet-Danon, D., Bachelot, G., Lionnet, F., Santin, A., Cordier, A. G., Kolanska, K., Lévy, R., Berthaut, I., & Dupont, C. (2026). Reproductive function and sperm parameters in men with sickle cell disease: a systematic review. Asian Journal of Andrology. https://doi.org/10.4103/aja202510
Vancouver
Leblanc C, Sermondade N, Ogouma-Aworet L, Ly A, Rivet-Danon D, Bachelot G, et al. Reproductive function and sperm parameters in men with sickle cell disease: a systematic review. Asian Journal of Andrology. 2026. doi:10.4103/aja202510
BibTeX
@article{Leblanc2026,
author = {Leblanc, Clarisse and Sermondade, Nathalie and Ogouma-Aworet, Ludmilla and Ly, Anna and Rivet-Danon, Diane and Bachelot, Guillaume and Lionnet, François and Santin, Aline and Cordier, Anne-Gaël and Kolanska, Kamila and Lévy, Rachel and Berthaut, Isabelle and Dupont, Charlotte},
title = {Reproductive function and sperm parameters in men with sickle cell disease: a systematic review},
journal = {Asian Journal of Andrology},
year = {2026},
doi = {10.4103/aja202510}
}
EUVIMED